Erika K Ross1, Joo Pyung Kim2, Megan L Settell3, Seong Rok Han4, Charles D Blaha3, Hoon-Ki Min5, Kendall H Lee6. 1. Department of Neurologic Surgery, Mayo Clinic, Rochester, MN 55905, USA; Mayo Graduate School, Mayo Clinic, Rochester, MN 55905, USA. 2. Department of Neurologic Surgery, Mayo Clinic, Rochester, MN 55905, USA; Department of Neurosurgery, Bundang CHA Hospital, CHA University School of Medicine, Seongnam, Korea. 3. Department of Neurologic Surgery, Mayo Clinic, Rochester, MN 55905, USA. 4. Department of Neurologic Surgery, Mayo Clinic, Rochester, MN 55905, USA; Department of Neurosurgery, Ilsan Paik Hospital, College of Medicine, Inje University, Goyang, Korea. 5. Department of Neurologic Surgery, Mayo Clinic, Rochester, MN 55905, USA; Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN 55905, USA. Electronic address: min.paul@mayo.edu. 6. Department of Neurologic Surgery, Mayo Clinic, Rochester, MN 55905, USA; Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN 55905, USA. Electronic address: lee.kendall@mayo.edu.
Abstract
INTRODUCTION: Deep brain stimulation (DBS) is a circuit-based treatment shown to relieve symptoms from multiple neurologic and neuropsychiatric disorders. In order to treat the memory deficit associated with Alzheimer's disease (AD), several clinical trials have tested the efficacy of DBS near the fornix. Early results from these studies indicated that patients who received fornix DBS experienced an improvement in memory and quality of life, yet the mechanisms behind this effect remain controversial. It is known that transmission between the medial limbic and corticolimbic circuits plays an integral role in declarative memory, and dysfunction at the circuit level results in various forms of dementia, including AD. Here, we aimed to determine the potential underlying mechanism of fornix DBS by examining the functional circuitry and brain structures engaged by fornix DBS. METHODS: A multimodal approach was employed to examine global and local temporal changes that occur in an anesthetized swine model of fornix DBS. Changes in global functional activity were measured by functional MRI (fMRI), and local neurochemical changes were monitored by fast scan cyclic voltammetry (FSCV) during electrical stimulation of the fornix. Additionally, intracranial microinfusions into the nucleus accumbens (NAc) were performed to investigate the global activity changes that occur with dopamine and glutamate receptor-specific antagonism. RESULTS: Hemodynamic responses in both medial limbic and corticolimbic circuits measured by fMRI were induced by fornix DBS. Additionally, fornix DBS resulted in increases in dopamine oxidation current (corresponding to dopamine efflux) monitored by FSCV in the NAc. Finally, fornix DBS-evoked hemodynamic responses in the amygdala and hippocampus decreased following dopamine and glutamate receptor antagonism in the NAc. CONCLUSIONS: The present findings suggest that fornix DBS modulates dopamine release on presynaptic dopaminergic terminals in the NAc, involving excitatory glutamatergic input, and that the medial limbic and corticolimbic circuits interact in a functional loop.
INTRODUCTION: Deep brain stimulation (DBS) is a circuit-based treatment shown to relieve symptoms from multiple neurologic and neuropsychiatric disorders. In order to treat the memory deficit associated with Alzheimer's disease (AD), several clinical trials have tested the efficacy of DBS near the fornix. Early results from these studies indicated that patients who received fornix DBS experienced an improvement in memory and quality of life, yet the mechanisms behind this effect remain controversial. It is known that transmission between the medial limbic and corticolimbic circuits plays an integral role in declarative memory, and dysfunction at the circuit level results in various forms of dementia, including AD. Here, we aimed to determine the potential underlying mechanism of fornix DBS by examining the functional circuitry and brain structures engaged by fornix DBS. METHODS: A multimodal approach was employed to examine global and local temporal changes that occur in an anesthetized swine model of fornix DBS. Changes in global functional activity were measured by functional MRI (fMRI), and local neurochemical changes were monitored by fast scan cyclic voltammetry (FSCV) during electrical stimulation of the fornix. Additionally, intracranial microinfusions into the nucleus accumbens (NAc) were performed to investigate the global activity changes that occur with dopamine and glutamate receptor-specific antagonism. RESULTS: Hemodynamic responses in both medial limbic and corticolimbic circuits measured by fMRI were induced by fornix DBS. Additionally, fornix DBS resulted in increases in dopamine oxidation current (corresponding to dopamine efflux) monitored by FSCV in the NAc. Finally, fornix DBS-evoked hemodynamic responses in the amygdala and hippocampus decreased following dopamine and glutamate receptor antagonism in the NAc. CONCLUSIONS: The present findings suggest that fornix DBS modulates dopamine release on presynaptic dopaminergic terminals in the NAc, involving excitatory glutamatergic input, and that the medial limbic and corticolimbic circuits interact in a functional loop.
Authors: Stephen M Smith; Mark Jenkinson; Mark W Woolrich; Christian F Beckmann; Timothy E J Behrens; Heidi Johansen-Berg; Peter R Bannister; Marilena De Luca; Ivana Drobnjak; David E Flitney; Rami K Niazy; James Saunders; John Vickers; Yongyue Zhang; Nicola De Stefano; J Michael Brady; Paul M Matthews Journal: Neuroimage Date: 2004 Impact factor: 6.556
Authors: Su-Youne Chang; Inyong Kim; Michael P Marsh; Dong Pyo Jang; Sun-Chul Hwang; Jamie J Van Gompel; Stephan J Goerss; Christopher J Kimble; Kevin E Bennet; Paul A Garris; Charles D Blaha; Kendall H Lee Journal: Mayo Clin Proc Date: 2012-07-16 Impact factor: 7.616
Authors: Garret D Stuber; Thomas S Hnasko; Jonathan P Britt; Robert H Edwards; Antonello Bonci Journal: J Neurosci Date: 2010-06-16 Impact factor: 6.167
Authors: Katja Hardenacke; Elena Shubina; Christian Philipp Bührle; Alexandra Zapf; Doris Lenartz; Joachim Klosterkötter; Veerle Visser-Vandewalle; Jens Kuhn Journal: Front Psychiatry Date: 2013-12-04 Impact factor: 4.157
Authors: Myung-Ho In; Shinho Cho; Yunhong Shu; Hoon-Ki Min; Matt A Bernstein; Oliver Speck; Kendall H Lee; Hang Joon Jo Journal: Neuroimage Date: 2017-06-27 Impact factor: 6.556
Authors: William S Gibson; Erika K Ross; Seong Rok Han; Jamie J Van Gompel; Hoon-Ki Min; Kendall H Lee Journal: Brain Stimul Date: 2016-04-15 Impact factor: 8.955
Authors: Nathalie Van Den Berge; Daniel L Albaugh; Andrew Salzwedel; Christian Vanhove; Roel Van Holen; Wei Gao; Garret D Stuber; Yen-Yu Ian Shih Journal: Neuroimage Date: 2016-11-05 Impact factor: 6.556
Authors: Helen N Schwerdt; Min Jung Kim; Satoko Amemori; Daigo Homma; Tomoko Yoshida; Hideki Shimazu; Harshita Yerramreddy; Ekin Karasan; Robert Langer; Ann M Graybiel; Michael J Cima Journal: Lab Chip Date: 2017-03-14 Impact factor: 6.799
Authors: Megan L Settell; Paola Testini; Shinho Cho; Jannifer H Lee; Charles D Blaha; Hang J Jo; Kendall H Lee; Hoon-Ki Min Journal: Front Neurosci Date: 2017-03-03 Impact factor: 4.677
Authors: Arvin Arani; Hoon-Ki Min; Nikoo Fattahi; Nicholas M Wetjen; Joshua D Trzasko; Armando Manduca; Clifford R Jack; Kendall H Lee; Richard L Ehman; John Huston Journal: Magn Reson Med Date: 2017-05-09 Impact factor: 4.668